CMP Therapeutics Readies EU Launch With An Eye On The U.S.
This article was originally published in The Tan Sheet
Executive Summary
CMP Therapeutics talks with large and small pharmas about distributing its micronized nasal spray, branded as Atlantic Secret. EU regulatory approval came seven years after the firm’s launch, but CEO Neil Moray Mackenzie expects much less time before a U.S. launch.